Epalrestat
Epalrestat št. CAS: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Zdravilo Epalrestat se uporablja za preprečevanje, izboljšanje in zdravljenje periferne nevropatije (otrplost, bolečina), vibracijske parestezije in srčnih motenj, povezanih s sladkorno boleznijo. SPECIFIKACIJA
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Zdravilo Epalrestat se uporablja za preprečevanje, izboljšanje in zdravljenje periferne nevropatije (otrplost, bolečina), vibracijske parestezije in srčnih motenj, povezanih s sladkorno boleznijo. SPECIFIKACIJA
P ime roduct | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Tukaj napišite svoje sporočilo in nam ga pošljite